Influence of nifedipine and enalapril on osmoregulation of vasopressin.
To determine whether calcium fluxes and angiotensin II influence osmoregulation of vasopressin (AVP) secretion, the effects of the calcium antagonist nifedipine and of the converting enzyme inhibitor enalapril on the AVP response to an osmotic load were compared to those of a placebo in seven normal female subjects. Plasma and urinary AVP were measured before and during a 3-h infusion of 2.5% hypertonic saline. Nifedipine (10 mg orally 2 h before and 10 mg at the start of the infusion) increased heart rate but did not change blood pressure. The changes in free water clearance and in urinary AVP induced by hypertonic saline under nifedipine were greater than in the control test, but the slope and the intercept of the regression line of plasma AVP upon plasma osmolality were not significantly different. Enalapril (10 mg 3 h before the infusion) did not change heart rate or blood pressure. Free water clearance and urinary AVP did not differ from the control test, but the slope of the regression line was less steep. These slight modifications of the response to an osmotic load suggest that calcium fluxes and angiotensin II only exert a limited influence on AVP osmoregulation in normal females.
D000806:Angiotensin-Converting Enzyme Inhibitors; D001127:Arginine Vasopressin / Q000378:metabolism*; D004656:Enalapril / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007473:Ion Channels / Q000378:metabolism; D009543:Nifedipine / Q000494:pharmacology*; D012083:Renin / Q000097:blood; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D007473:Ion Channels; D001127:Arginine Vasopressin; D004656:Enalapril; D012083:Renin; D009543:Nifedipine